An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19)
Authors
Keywords
-
Journal
CLINICAL DRUG INVESTIGATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-29
DOI
10.1007/s40261-020-00927-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Case Report: Right Bundle Brunch Block and QTc Prolongation in a Patient with Novel Coronavirus Disease (COVID-19) Treated with Hydroxychloroquine
- (2020) Rosmonaliza Asli et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19
- (2020) Alfred H.J. Kim et al. ANNALS OF INTERNAL MEDICINE
- Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society
- (2020) John L. Sapp et al. CANADIAN JOURNAL OF CARDIOLOGY
- Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?
- (2020) Maurizio Guastalegname et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties
- (2020) Cornelis Smit et al. CLINICAL PHARMACOKINETICS
- New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
- (2020) Christian A. Devaux et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
- (2020) Jacques Fantini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease‐19 (COVID‐19)
- (2020) Sanket Shah et al. International Journal of Rheumatic Diseases
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated with Hydroxychloroquine and/or Azithromycin
- (2020) David Chang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Hydroxychloroquine prophylaxis for COVID-19 contacts in India
- (2020) Sahaj Rathi et al. LANCET INFECTIOUS DISEASES
- The Urgency of Care during the Covid-19 Pandemic — Learning as We Go
- (2020) Eric J. Rubin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
- (2020) Matthieu Million et al. Travel Medicine and Infectious Disease
- Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
- (2020) Philippe Gautret et al. Travel Medicine and Infectious Disease
- Chloroquine and hydroxychloroquine in covid-19
- (2020) Robin E Ferner et al. BMJ-British Medical Journal
- Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base
- (2020) Fabio S Taccone et al. Lancet Respiratory Medicine
- Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Nicholas J. Mercuro et al. JAMA Cardiology
- Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
- (2020) Riccardo M. Inciardi et al. JAMA Cardiology
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
- (2020) Katelyn A Pastick et al. Open Forum Infectious Diseases
- Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
- (2020) Erin K McCreary et al. Open Forum Infectious Diseases
- Finding the Dose for Hydroxychloroquine Prophylaxis for COVID‐19: The Desperate Search for Effectiveness
- (2020) Mahmoud Al‐Kofahi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards
- (2020) Bernard La Scola et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
- (2020) J.M. Molina et al. MEDECINE ET MALADIES INFECTIEUSES
- In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
- (2020) Julien Andreani et al. MICROBIAL PATHOGENESIS
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection
- (2018) Pierre Roques et al. Viruses-Basel
- Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis
- (2017) Sergey A. Shiryaev et al. Scientific Reports
- Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model
- (2015) Stuart D. Dowall et al. JOURNAL OF GENERAL VIROLOGY
- Hydroxychloroquine-Inhibited Dengue Virus Is Associated with Host Defense Machinery
- (2015) Li-Fong Wang et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors
- (2015) Encouse B. Golden et al. Neurosurgical Focus
- Chloroquine use improves dengue-related symptoms
- (2014) Marcos Carvalho Borges et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial
- (2011) Nicholas I Paton et al. LANCET INFECTIOUS DISEASES
- Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases
- (2009) Kirk Sperber et al. Pediatric Rheumatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now